Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson says its Centocor unit bought British lung disease drug developer RespiVert
Johnson & Johnson says its Centocor unit bought British lung disease drug developer RespiVert
Johnson & Johnson says its Centocor unit bought British lung disease drug developer RespiVert
Submitted by
admin
on June 1, 2010 - 9:05am
Source:
Yahoo/AP
News Tags:
JNJ
Janssen Biotech
RespiVert
M&A
Headline:
Johnson & Johnson says its Centocor unit bought British lung disease drug developer RespiVert
Do Not Allow Advertisers to Use My Personal information
